JP2024534720A5 - - Google Patents
Info
- Publication number
- JP2024534720A5 JP2024534720A5 JP2024506903A JP2024506903A JP2024534720A5 JP 2024534720 A5 JP2024534720 A5 JP 2024534720A5 JP 2024506903 A JP2024506903 A JP 2024506903A JP 2024506903 A JP2024506903 A JP 2024506903A JP 2024534720 A5 JP2024534720 A5 JP 2024534720A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- cells
- nucleic acid
- acid sequence
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163203996P | 2021-08-06 | 2021-08-06 | |
| US63/203,996 | 2021-08-06 | ||
| PCT/US2022/074625 WO2023015307A1 (en) | 2021-08-06 | 2022-08-05 | Method for producing genetically modified cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534720A JP2024534720A (ja) | 2024-09-25 |
| JP2024534720A5 true JP2024534720A5 (enExample) | 2025-08-14 |
Family
ID=85156349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506903A Pending JP2024534720A (ja) | 2021-08-06 | 2022-08-05 | 遺伝子改変細胞を作製するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250109413A1 (enExample) |
| EP (1) | EP4380627A4 (enExample) |
| JP (1) | JP2024534720A (enExample) |
| KR (1) | KR20240043783A (enExample) |
| CN (1) | CN118159301A (enExample) |
| AU (1) | AU2022324118A1 (enExample) |
| CA (1) | CA3227964A1 (enExample) |
| WO (1) | WO2023015307A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3957731A1 (en) | 2015-07-15 | 2022-02-23 | Rutgers, The State University of New Jersey | Nuclease-independent targeted gene editing platform and uses thereof |
| CN121941763A (zh) * | 2023-09-29 | 2026-04-28 | 味之素株式会社 | Hla基因修饰细胞 |
| WO2025117745A1 (en) * | 2023-12-01 | 2025-06-05 | Caribou Biosciences, Inc. | Methods and compositions for improving precision of endonuclease-mediated genome editing |
| WO2025179057A1 (en) * | 2024-02-21 | 2025-08-28 | The Regents Of The University Of California | In vivo modification of cell genomes |
| WO2025255010A1 (en) * | 2024-06-03 | 2025-12-11 | X Development Llc | Ai-guided synthetic biology development platform, systems, and methods |
| WO2026158558A1 (zh) * | 2025-01-26 | 2026-07-30 | 华夏英泰（北京）生物技术有限公司 | 用于制备经遗传修饰的细胞的非电转方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3027428A1 (en) * | 2016-06-14 | 2017-12-21 | Regents Of The University Of Minnesota | Genetically modified cells, tissues, and organs for treating disease |
| CN112292139B (zh) * | 2018-03-13 | 2024-03-08 | 明尼苏达大学董事会 | 使用Cas9碱基编辑器的淋巴造血改造 |
| AU2020466994B2 (en) * | 2019-09-17 | 2026-05-28 | Rutgers, The State University Of New Jersey | Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof |
| EP4041759A4 (en) * | 2019-10-07 | 2023-12-20 | Fate Therapeutics, Inc. | IMPROVED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTIVE CELL ENGINEERING AND ITS USE |
-
2022
- 2022-08-05 KR KR1020247007517A patent/KR20240043783A/ko active Pending
- 2022-08-05 JP JP2024506903A patent/JP2024534720A/ja active Pending
- 2022-08-05 WO PCT/US2022/074625 patent/WO2023015307A1/en not_active Ceased
- 2022-08-05 CA CA3227964A patent/CA3227964A1/en active Pending
- 2022-08-05 AU AU2022324118A patent/AU2022324118A1/en active Pending
- 2022-08-05 US US18/681,775 patent/US20250109413A1/en active Pending
- 2022-08-05 EP EP22854129.8A patent/EP4380627A4/en active Pending
- 2022-08-05 CN CN202280067317.XA patent/CN118159301A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210008161A1 (en) | Methods and compositions for improved homology directed repair | |
| KR102796744B1 (ko) | 이식의 개선을 위한 crispr/cas-관련 방법 및 조성물 | |
| Akhmetov et al. | Single-step precision genome editing in yeast using CRISPR-Cas9 | |
| JP2024073596A5 (enExample) | ||
| EP3724326A1 (en) | Cpf1-related methods and compositions for gene editing | |
| WO2019011118A1 (zh) | 一种基因编辑系统及基因编辑的方法 | |
| KR20230096134A (ko) | 게놈 조작 | |
| CN105121641A (zh) | Rna-引导的人类基因组工程化 | |
| US20230235305A1 (en) | Cells modified by a cas12i polypeptide | |
| Merkert et al. | Targeted genome engineering using designer nucleases: State of the art and practical guidance for application in human pluripotent stem cells | |
| AU2022324118A1 (en) | Method for producing genetically modified cells | |
| CN116716298A (zh) | 一种引导编辑系统和目的基因序列的定点修饰方法 | |
| EP3896158A1 (en) | Method for inducing deletion in genomic dna | |
| CN117535354A (zh) | 一种修复hba2基因突变的方法、组合物及其应用 | |
| US12359247B2 (en) | Methods of performing GUIDE-Seq on primary human T cells | |
| Yoon et al. | Intramitochondrial transfer and engineering of mammalian mitochondrial genomes in yeast | |
| WO2023225358A1 (en) | Generation and tracking of cells with precise edits | |
| CA3246348A1 (en) | RT-DNA AND RETRONS FIDELITY GENOMIC EDITING | |
| US20260043048A1 (en) | High-throughput in vivo dna recombineering | |
| CN113528437B (zh) | 一种增强基因编辑效率的试剂盒及其应用 | |
| WO2024023734A1 (en) | MULTI-gRNA GENOME EDITING | |
| CN113564205B (zh) | 一种平衡染色体动物模型的构建方法 | |
| WO2025120664A1 (en) | Strategies for precision editing of homologous regions | |
| Ruis et al. | SETDB1/ATF7IP regulate the precise genome engineering of HUSH-regulated genes | |
| US20230407278A1 (en) | Compositions and methods for cas9 molecules with improved gene editing properties |